Molecular design improved by searching continuous synthesis routes space
Navigating Route Latent Space for Synthesizable Molecular Design
Artificial IntelligenceComputational Engineering, Finance, and Science
Summary
Designing new molecules often hits a roadblock because many are hard to make in real life. The authors found that searching in the usual way misses the smooth paths that connect easy-to-make molecules. They created RouteFlow, a method that looks through a continuous space of possible synthesis plans, making sure the molecules can actually be built. This helps find molecules that are both useful and practical to produce.
What this means in practice
- •For pharmaceutical chemists: Generate drug leads that are guaranteed to have feasible synthesis routes, speeding up the experimental testing phase.
- •For chemical manufacturing planners: Plan production routes for novel molecules with optimized properties while ensuring they remain practical and cost-effective to synthesize.
Authors
Tao Li, Tuan Vinh, Monika Raj, Yuan Fang, Zhichun Guo, Carl Yang
Abstract
Goal-directed molecular design has advanced rapidly, yet a substantial proportion of designed molecules remain difficult to synthesize in practice, limiting their real-world utility. Prior synthesizability-aware methods either project generated molecules back to synthesizable analogs that deviate from the intended target, or optimize directly in discrete synthesis spaces that lack a continuous landscape for efficient search. We argue that this limitation mainly comes from the search space rather than the optimizer. To address this, we propose RouteFlow, a framework that reformulates synthesizable molecular design as a search over a continuous route latent space, where each latent maps back to a complete synthesis route and synthesizability is inherently preserved. To navigate this space, we adopt reward-guided flow matching as an efficient sampler that steers toward high-property regions. Since reward optimization may push latents off the manifold of real synthesis routes, where decoding becomes unreliable, we further introduce a cycle-consistency mechanism to stabilize fine-tuning. Across 16 optimization tasks from Therapeutic Data Commons, RouteFlow achieves the best sample efficiency among synthesizability-aware baselines, with the best synthetic accessibility and the highest retrosynthesis success rate. Our results also confirm that the proposed cycle-consistency reliably keeps optimization on-manifold while improving target properties, supporting effective synthesizable molecular discovery.